Atlas Trials

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children

Clinical trial NCT01982396 · COMPLETED

Trial details

NCT number
NCT01982396
Sponsor
PENTA Foundation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infection
Start date
2003-01-01
Primary completion
2004-02-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.